BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 38003482)

  • 21. Radiogenomics in Renal Cancer Management-Current Evidence and Future Prospects.
    Ferro M; Musi G; Marchioni M; Maggi M; Veccia A; Del Giudice F; Barone B; Crocetto F; Lasorsa F; Antonelli A; Schips L; Autorino R; Busetto GM; Terracciano D; Lucarelli G; Tataru OS
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case Report: Pancreatic metastasis of renal cell carcinoma 16 years after nephrectomy.
    Lou Y; Guo K; Zheng S
    Front Oncol; 2023; 13():1091635. PubMed ID: 36845747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and Efficacy of Surgery for Metastatic Tumor to the Pancreas: A Single-Center Experience.
    Moletta L; Friziero A; Serafini S; Grillo V; Pierobon ES; Capovilla G; Valmasoni M; Sperti C
    J Clin Med; 2023 Feb; 12(3):. PubMed ID: 36769817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolated Pancreatic Metastases of Renal Cell Carcinoma-Clinical Particularities and Seed and Soil Hypothesis.
    Sellner F; Thalhammer S; Klimpfinger M
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of tumor-derived exosomes in metastasis, drug resistance and diagnosis of clear cell renal cell carcinoma.
    Jiang T; Zhu Z; Zhang J; Chen M; Chen S
    Front Oncol; 2022; 12():1066288. PubMed ID: 36620603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Overview of Epigenetics in Clear Cell Renal Cell Carcinoma.
    Grammatikaki S; Katifelis H; Farooqi AA; Stravodimos K; Karamouzis MV; Souliotis K; Varvaras D; Gazouli M
    In Vivo; 2023; 37(1):1-10. PubMed ID: 36593023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of Tumor and Metastasis Initiation by Chemokine Receptors.
    DiNatale A; Castelli MS; Nash B; Meucci O; Fatatis A
    J Cancer; 2022; 13(11):3160-3176. PubMed ID: 36118530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression.
    Cignoli D; Fallara G; Aleotti F; Larcher A; Rosiello G; Rowe I; Basile G; Colandrea G; Martini A; De Cobelli F; Brembilla G; Lucianò R; Colecchia M; Lena MS; Partelli S; Tamburrino D; Zamboni G; Rubini C; Falconi M; Montorsi F; Salonia A; Capitanio U
    World J Urol; 2022 Oct; 40(10):2481-2488. PubMed ID: 35904571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammation-associated premetastatic niche formation.
    Deguchi A; Maru Y
    Inflamm Regen; 2022 Jul; 42(1):22. PubMed ID: 35780158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of HIF on metabolism and immunity.
    Taylor CT; Scholz CC
    Nat Rev Nephrol; 2022 Sep; 18(9):573-587. PubMed ID: 35726016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metastasis From Clear Cell Renal Cell Carcinoma Mimicking Well-Differentiated Pancreatic Neuroendocrine Tumor at 18F-FDG and 68Ga-DOTATOC PET/CT.
    Guglielmo P; Pesella F; Sartorello A; El Khouzai B; Berti S; Muccioli S; Gregianin M
    Clin Nucl Med; 2022 Jul; 47(7):e498-e499. PubMed ID: 35675141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeat pancreatic resection for metachronous pancreatic metastasis from renal cell carcinoma: A case report.
    Itamoto S; Abe T; Oshita A; Hanada K; Nakahara M; Noriyuki T
    Int J Surg Case Rep; 2022 May; 94():107022. PubMed ID: 35398785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic regulation of CXCR4 signaling in cancer pathogenesis and progression.
    Alsayed RKME; Khan AQ; Ahmad F; Ansari AW; Alam MA; Buddenkotte J; Steinhoff M; Uddin S; Ahmad A
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):697-708. PubMed ID: 35346802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolated Pancreatic Metastases of Renal Cell Cancer: Genetics and Epigenetics of an Unusual Tumour Entity.
    Sellner F; Thalhammer S; Klimpfinger M
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgery of pancreatic metastasis from renal cell carcinoma.
    Vilar Tabanera A; Muñoz Muñoz P; Molina Villar JM; Gajate P; Sanjuanbenito A
    Cir Esp (Engl Ed); 2022 Jan; 100(1):50-52. PubMed ID: 34863662
    [No Abstract]   [Full Text] [Related]  

  • 36. A case of hemobilia caused by pancreatic metastasis of renal cell carcinoma treated with a covered metallic stent.
    Yamawaki M; Takano Y; Noda J; Azami T; Kobayashi T; Niiya F; Maruoka N; Yamagami T; Nagahama M
    Clin J Gastroenterol; 2022 Feb; 15(1):210-215. PubMed ID: 34637048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal cell carcinoma with unusual metachronous metastasis up to 22 years after nephrectomy: two case reports.
    Bruckschen F; Gerharz CD; Sagir A
    J Med Case Rep; 2021 Oct; 15(1):490. PubMed ID: 34607612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of Von Hippel-Lindau (
    Kim H; Shim BY; Lee SJ; Lee JY; Lee HJ; Kim IH
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deficiency of the X-inactivation escaping gene
    Zheng Q; Li P; Zhou X; Qiang Y; Fan J; Lin Y; Chen Y; Guo J; Wang F; Xue H; Xiong J; Li F
    Theranostics; 2021; 11(18):8674-8691. PubMed ID: 34522206
    [No Abstract]   [Full Text] [Related]  

  • 40. Determining the immunohistochemical expression of GLUT1 in renal cell carcinoma using the HSCORE method.
    Ogorevc M; Strikic A; Tomas SZ
    Biomed Rep; 2021 Oct; 15(4):79. PubMed ID: 34429965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.